Prevalence of most common human pathogenic Campylobacter spp. in dogs and cats in Styria, Austria

Veterinary Medicine and Science
Thomas PölzlerHeimo Lassnig

Abstract

The aim of this study was to determine the frequency of occurrence of most common human pathogenic Campylobacter species, Campylobacter jejuni (C. jejuni) and Campylobacter coli (C. coli), in dogs and cats in Styria, Austria. In the period from April 2010 to April 2012, 842 faecal samples from dogs and cats from Styria, Austria were examined for Campylobacter (C.) species (spp.). All samples were subjected to qualitative microbiological culture testing, and additionally, some of them have been studied using qualitative real-time PCR. In microbiological culture, 5.9% of all samples investigated were C. spp. positive. With 3.1% out of positive samples, C. jejuni was the most common type. Campylobacter upsaliensis (C. upsaliensis) was detected only in 0.5% of the samples. The remaining positive samples (2.4%) were classified as C. species (sp.). C. coli could not be found in any of the samples. A higher prevalence of C. jejuni was found in kittens with 14.3% and in diarrhoeic dogs (7.4%) and cats (23.8%). The real-time PCR revealed for dogs and cats together, 27% of C. jejuni-positive faecal and 8% positive faecal swap samples. The obtained C. jejuni strains underwent antibiotic resistance testing using three different tests (agar...Continue Reading

References

May 1, 1992·Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B·A P BurnensJ Nicolet
Oct 15, 1983·The Veterinary Record·M P Fleming
Oct 10, 1997·FEMS Immunology and Medical Microbiology·E M NielsenM Madsen
Dec 13, 1997·The Journal of Infectious Diseases·B M Allos
Dec 13, 1997·The Journal of Infectious Diseases·J C BuzbyT Roberts
Jan 22, 2002·Bulletin Du Groupèment International Pour La Recherche Scientifique En Stomatologie & Odontologie·P LibersaB Pertuzon
Aug 27, 2002·Emerging Infectious Diseases·Iain A GillespieUNKNOWN Campylobacter Sentinel Surveillance Scheme Collaborators
Nov 11, 2003·Scandinavian Journal of Infectious Diseases·Eva Olsson EngvallLena Englund
Feb 10, 2004·Journal of Clinical Microbiology·M G J KoeneJ A Wagenaar
Mar 9, 2004·Journal of Clinical Microbiology·Peter DamborgLuca Guardabassi
Mar 4, 2005·Journal of the American Veterinary Medical Association·Jeffrey B BenderBert E Stromberg
Apr 23, 2005·Veterinary Research·John E MoorePaul Whyte
Jul 8, 2005·Journal of Veterinary Medicine. B, Infectious Diseases and Veterinary Public Health·B WielandK D C Stärk
Dec 12, 2007·Letters in Applied Microbiology·A GargiuloL F Menna
Sep 26, 2009·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Petra MullnerNigel P French
May 23, 2013·Polish Journal of Veterinary Sciences·M AndrzejewskaM Chudzińska
May 9, 2015·The Veterinary Journal·M GiacomelliA Piccirillo

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Campylobacteriosis (ASM)

Campylobacteriosis is caused by the bacteria Campylobacter jejuni and is a common cause of gastroenteritis in humans. Discover the latest research on Campylobacteriosis here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.